kaal:position:2026-07-31-3078

Regulation of mRNA export through API5 and nuclear FGF2 interaction should be assessed against Kaal's source-bound claim that Data derived from venture capital investments can function as a dynamic regulatory supplement for disruptive innovation, because venture capital's financial allocations to innovative projects supply feedback for dynamic regulation. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

Affirmed commentary position. This record extends a source-bound scholarly claim but is not a verbatim paper claim.

Holds when

where venture capital investment allocation data is available to regulators
United States venture capital market, 2005 to 2015
External evidence level: abstract indexed.
Mapping review tier: ambiguity triage before claim review.
The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence.

Current debate

Regulation of mRNA export through API5 and nuclear FGF2 interaction

Scholarly basis

kaal:claim:2808132-006
Wulf A. Kaal, Erik P.M. Vermeulen, How to Regulate Disruptive Innovation - From Facts to Data (2016). SSRN: https://ssrn.com/abstract=2808132
Source PDF sha256: 3515f2317ed9c1d33ae55d70467cdf1f6c4e350065ea6a887d5d7619599ad7d2

Evidence and mapping

Evidence: abstract indexed
Review tier: ambiguity triage before claim review
Mapping confidence: 0.234
Mapping ambiguous: true

Topics

innovationdynamic-regulationinstitutional-design

Provenance

Affirmed in historical-backfill:2026-07-31:phase-0013 on 2026-07-31. Review record.

Verify

Canonical markdown sha256: b7fd4f033bb54f3edb84c62148305873344430f564a0860927e9c36f5eb1c277
curl -s https://wulfkaal.github.io/positions/2026-07-31-3078.md | sha256sum